Selective induction of gene expression in rat lung by hexavalent chromium
- 24 September 2002
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 35 (2) , 75-84
- https://doi.org/10.1002/mc.10077
Abstract
Multigene‐expression analysis provides a formidable tool for evaluating cellular functions, under either physiological or pathological conditions, and for assessing their modulation by exogenous agents. We investigated multigene expression in the liver and lung of rats receiving intratracheal instillations of sodium dichromate for 3 consecutive days. Nylon membrane cDNA arrays were hybridized with standardized amounts of 32P‐labeled probes, and the results were normalized by making reference to housekeeping genes. The basal expression of 52 of 216 tested genes was 2.1–11.1 times higher in the liver than in the lung of control rats. No alteration of gene expression occurred in the liver of chromium(VI)‐treated rats, consistent with the fact that this metal species, being reduced upstream, can exert effects only locally but not at a distance from the respiratory tract. In contrast, the expression of 56 genes was increased 2.1 to 3.0 times in the lung as an early response to chromium(VI) administration. The altered genes are involved in the metabolic reduction of chromium(VI) and in a variety of interconnected functions, such as multidrug resistance and stress response, protein and DNA repair mechanisms, signal transduction pathways, apoptosis, and cell‐cycle modulation. Thus, short‐term treatment with chromium(VI) by intratracheal administration triggered a variety of defense processes in the lung. Although the use of selected genes does not provide an exhaustive picture of overall gene expression, these findings contribute to our understanding of chromium toxicology and provide a further mechanistic support to the involvement of thresholds in chromium(VI) carcinogenesis.Keywords
This publication has 32 references indexed in Scilit:
- Lung cancer among workers in chromium chemical productionAmerican Journal of Industrial Medicine, 2000
- DNA fragmentation, DNA-protein crosslinks, 32P postlabeled nucleotidic modifications, and 8-hydroxy-2′-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of chromium(VI). Chemoprevention by oral N-acetylcysteineMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicityCarcinogenesis: Integrative Cancer Research, 1997
- Reduction of Chromium(VI) by Ascorbate Leads to Chromium-DNA Binding and DNA Strand Breaks in VitroBiochemistry, 1995
- Chromium in urine, serum and red blood cells in the biological monitoring of workers exposed to different chromium valency statesScience of The Total Environment, 1988
- Carcinogenicity study with sodium dichromate in ratsExperimental pathology, 1986
- Formation and persistence of benzo(a)pyrene metabolite-DNA adducts.Environmental Health Perspectives, 1985
- Long‐term study of the distribution of soluble chromate‐51 in the rat after a single intratracheal administrationJournal of Toxicology and Environmental Health, 1983
- Xenobiotic metabolism by alveolar type II cells isolated from rabbit lungBiochemical Pharmacology, 1981
- Metabolic deactivation of mutagens in the Salmonella-microsome testNature, 1978